Purpose

Patients undergoing buccal urethroplasty will often have significant post-operative oral pain from the graft site. Various graft harvest techniques and methods for post-harvest hemostasis including graft site closure have been explored. Despite the frequency of this clinical scenario there is no established best practice for peri-operative pain management in this patient population. In addition to traditional post operative pain control, groups have sought various peri-operative anesthetic regimens to improve post operative pain. This has led recently to the description of various regional blocks including buccal and periorbital blocks for peri-operative local anesthetic. No study has looked at superiority of regional pain management in this patient population. This study will aim to assess three established anesthetic protocols for oral pain control in a blinded, randomized controlled trial. Hypothesis: Patients who have buccal block will have lower post op pain without any increase adverse oral outcomes.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Men, age 18 or older - Undergoing anterior urethroplasty with buccal grafting - Able to consent

Exclusion Criteria

  • Taking chronic opiates for pain - Diagnosis of chronic pain - Prior buccal urethroplasty - Vulnerable population (e.g. prisoner) - Renal dysfunction or allergy preventing NSAID use - Liver dysfunction or allergy preventing Tylenol use - Medical allergy to local anesthetic - Medical allergy to Peridex/Magic Mouthwash - NYHA Class III/IV - Hematologic condition that excludes patient from surgery - Post-operative complication resulting in inpatient stay - Anesthetic complication - No buccal site surgical complication

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
This is a blinded, randomized, controlled trial following patients undergoing buccal urethroplasty (see criteria). This study will aim to assess three established anesthetic protocols for oral pain control. Each study arm holds equal weight.
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description
Approximately 60 subjects will be randomized in a 1:1:1 ratio to receive 3 different local anesthetic regimens following buccal graft harvest. The care provider administering will not be masked to the type of block, but they will be blinded to the post op outcomes.

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Group 1: Standard of care
1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. No further infiltration of local anesthetic in mouth
  • Drug: Standard Buccal Harvest
    Our institutions current anesthetic regimen. Comparison group
Experimental
Group 2: Standard of care + Long acting local
1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration in the buccal graft site
  • Drug: Basic buccal procedure + Long acting local
    Addition of long-acting local anesthetic to the wound bed following the oral graft harvest.
Experimental
Group 3: Standard of care + Buccal block
1. Prior to graft harvest - infiltration of 1% lidocaine with 1:100,000 epinephrine up to a maximum of 10 mL 2. Routine, standard graft site hemostasis with monopolar cautery 3. No suture closure of graft site 4. Up to a maximum of 10mL of 0.5% bupivacaine infiltration as a buccal block
  • Drug: Basic buccal procedure + Buccal block
    Addition of long-acting local anesthetic as a buccal block after oral graft harvest

Recruiting Locations

MedStar Urology
Washington, District of Columbia 20037
Contact:
Nathan Shaw, MD
202-444-4922
nathan.m.shaw@medstar.net

More Details

Status
Recruiting
Sponsor
University of California, San Francisco

Study Contact

Lindsay A Hampson, MD
415-353-2200
lindsay.hampson@ucsf.edu

Detailed Description

This is a blinded, randomized, controlled trial following patients undergoing buccal urethroplasty (see criteria). This study will aim to assess three established anesthetic protocols for oral pain control. Each study arm holds equal weight. Approximately 60 subjects will be randomized in a 1:1:1 ratio to receive the following graft harvest techniques, which are all considered standard of care. Group 1: Current Buccal Harvest - Infiltration of lidocaine 1% with 1:100,000 epinephrine (maximum 10cc) - Graft site hemostasis with monopolar cautery - No suture closure of graft site Group 2: Basic buccal procedure + Long acting local - Infiltration of lidocaine 1% with epinephrine (maximum 10cc) - Graft site hemostasis with monopolar cautery - No suture closure of graft site - 0.5% Marcaine (maximum 5cc) at case conclusion Group 3: Basic buccal procedure + Buccal block - Infiltration of lidocaine 1% with epinephrine (maximum 10cc) - Graft site hemostasis with monopolar cautery - No suture closure of graft site - Buccal block with 0.5% Marcaine (maximum 5cc) at case conclusion

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.